TP53 and cancer: The novel finding in present study is that the increased levels of ceramide (Figures 2B, 2C, 8A, 8B), rather than decreased levels of glycosphingolipids, eliminated oncogenic GOF of p53 in iPSC, via reactivation of wt p53 expression in cancer cells carrying a heterozygous p53 missense mutation.